近期论文
查看导师最新文章
（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）
Mei W, Jin L, Zhang B, Sun X, Liu X, Xin S, Zhang J, Yang G, Li S*, Ye L*. A Moonlighting Gene Signature for Prognosis and Immune Microenvironment Estimation in Prostate Cancer. Frontier in Oncology. 2022.9.8 Accept. (JCR Q2, IF5.738)（通讯作者）
Jin L†, Mei W†, Liu X, Sun X, Xin S, Zhou Z, Zhang J, Zhang B, Chen P*,Cai M*, Ye L*. Identification of cuproptosis -related subtypes, the development of a prognosis model, and characterization of tumor microenvironment infiltration in prostate cancer. Frontiers in Immunology 2022,13:974034.doi: 10.3389/fimmu.2022.974034.(JCR Q1, IF8.786)（通讯作者）
Liu X, Mei W, Jin L, Sun X, Xin S, Huang L, Yang G, Wang J*,Ye L*. Ubiquitin-related lncRNAs: the new tool for prognosis prediction in prostate cancer. Frontiers in Oncology 2022,12:948113. doi: 10.3389/fonc.2022.948113. (JCR Q2, IF5.738)（通讯作者）
Mei W†, Liu X†, Jia X, Jin L, Xin S, Sun X, Zhang J, Zhang B, Chen Y, Che J, Ma W*, Ye L*. A Cuproptosis-Related Gene Model for Predicting the Prognosis of Clear Cell Renal Cell Carcinoma. Frontier in Genetics 2022,13:905518.doi: 10.3389/fgene.2022.905518.(JCR Q1, IF4.772)（通讯作者）
Sun X #, Xin S#, Zhang Y, Jin L, Liu X, Zhang J, Mei W, Zhang B, Ma W*,Ye L*. The long non-coding RNA CASC11 promotes prostate cancer progression via YBX1-mediated suppression of p53 pathway. International Journal of Oncology. 2022 Sep;61(3):110. doi: 10.3892/ijo.2022.5400. Epub 2022 Jul 29.(JCR Q2, IF5.884)（通讯作者）
Sun X, Xin S, Li W, Zhang Y*, Ye L*. Discovery of Notch Pathway-Related Genes for Predicting Prognosisand Tumor Microenvironment Status in Bladder Cancer. Frontier in Genetics, 2022 Jun 30;13:928778. doi: 10.3389/fgene.2022.928778. eCollection 2022.(JCR Q1, IF4.772)（通讯作者）
Mei W#, Jia X#, Xin S, Liu X, Jin L, Sun X, Zhang J, Zhang B, Yang G, Chen P*, Ye L*. A N7-Methylguanine-Related Gene Model for Predicting the Prognosis of Prostate Cancer. Journal of Oncology.2022 May 13;2022:8604216. doi: 10.1155/2022/8604216. eCollection 2022. (JCR Q2, IF4.501)（通讯作者）
Xin S#, Sun X#, Jin L, Li W, Liu X, Zhou L*, Ye L*. The prognostic signature and therapeutic value of phagocytic regulatory factors in Prostate Adenocarcinoma(PRAD). Frontiers in Genetics. 30 May 2022 | https://doi.org/10.3389/fgene.2022.877278 (JCR Q1, IF4.772)（通讯作者）
Sun X#, Zhang Y#, Chen Y#, Xin S, Jin L, Liu X, Zhou Z, Zhang J, Mei W, Zhang B, Yao X*, Yang G*, Ye L*. In silico establishment and validation of novel lipid metabolism related gene signature in bladder cancer. Oxidative Medicine and Cellular Longevity. 2022 Apr 18;2022:3170950. doi: 10.1155/2022/3170950. eCollection 2022. (JCR Q2, IF7.31)（通讯作者）
Xin S, Sun X, Jin L, Zhou Z, Liu X, Li W, Mei W, Zhang J, Zhang B, Yao X, Zhou L*, Ye L*, Identifying the Potential Role and Prognostic Value of the Platelet-Derived Growth Factor Pathway in Kidney Renal Clear Cell Carcinoma, Journal of Oncology. vol. 2022, Article ID 9498010, 20 pages, 2022. https://doi.org/10.1155/2022/9498010 (JCR Q2, IF4.501)（通讯作者）
Zhou Z#, Shi H-J#, Jin L, Liu X, Zhai T-S, Zhang J-X, Ye L*. Prognostic Significance in Patients with Stage III–IV Upper tract urothelial carcinoma According to Age, Sex, Race, and Socioeconomic Status. Actas Urologicas Espanolas.2022.3.11.In Press.(JCR Q4, IF 0.994)（通讯作者）
Sun X#, Zhou Z#, Zhang Y, Wang J, Zhao X, Jin L, Zhai T, Liu X, Zhang J, Mei W, Zhang B, Luo M*, Yao X*, Ye L*. Identification and validation of a hypoxia-related prognostic and immune microenvironment signature in bladder cancer. Cancer Cell International. 2021 May 7;21(1):251. doi: 10.1186/s12935-021-01954-4. (JCR Q2, IF 6.429) （通讯作者）
Zhou Z#, Yue F#, Jin L#, Liu X, Zhai T-S, Zhang J-X, Gu W-Y, Liu S-H, Luo M, Peng B, Yao X-D, Ye L*. Characteristics and risk differences of different tumor size on localised prostate cancer: A retrospective cohort study in the SEER database. Cancer Medicine. 2021 Apr;10(8):2763-2773. doi: 10.1002/cam4.3856. Epub 2021 Mar 16. (JCR Q2, IF4.711) （通讯作者）
Zhai T-S, Hu L-T, Ma W-G, Chen X, Luo M, Jin L, Zhou Z, Liu X, Kang Y, Kang Y-X, Zhang J-X, Liu H, Lu J-Y*, Yao X-D*, Ye L*. Peri-prostatic fat measurements using MRI predict prostate cancer aggressiveness in men undergoing radical prostatectomy. Journal of Endocrinological Investigation. 2021 Feb;44(2):287-296. doi: 10.1007/s40618-020-01294-6. Epub 2020 May 30. (JCR Q2, IF5.467)（通讯作者）
Yu Y#, Yang F-H#, Zhang W-T, Guo Y-D, Ye L*, Yao X-D*. Mesenchymal stem cells desensitize castration-resistant prostate cancer to docetaxel chemotherapy via inducing TGF-β1-mediated cell autophagy. Cell And Bioscience. 2021 Jan 7;11(7). doi: 10.1186/s13578-020-00494-0.( JCR Q1, IF 9.584)（共同通讯作者）
Liu M#, Zhai T-S#, Feng L-J, lyu X-S, Hu L-T, Wang Z-X, Ma W-G, Zhan J, Zhao X-F, Chen X, Su B-J, Yao X-D, Lu J-Y, Ye L*. Incidental para-ureteral aggressive angiomyxoma: A rare case report and review of the literature. BMC Urology. 2020 Nov 10;20(1):182. doi: 10.1186/s12894-020-00755-7. (JCR Q3, IF2.09)（通讯作者）
Zhai T-S#, Jin L#, Feng L-M#, Zhou Z, Liu X, Liu H, Ma W-G, Lu J-Y, Chen W, Yao X-D*, Ye L*. Perioperative chemotherapy on survival in patients with upper urinary tract urothelial carcinoma undergoing nephroureterectomy: A Population-Based Study. Frontiers in Oncology. 2020 Apr 10:481. doi: 10.3389/fonc.2020.00481. eCollection 2020. (JCR Q2, IF5.738)（通讯作者）
Zhai, T-S#, Jin L#, Hu L-T#, Kadier A, Zhou Z, Liu X, Liu H, Li S, Lu J-Y, Yao X-D*, Ye L*. Impact of peri-prostatic fat measurements using MRI on the prediction of prostate cancer with transrectal ultrasound-guided biopsy. Urologic Oncology-Seminars and Original Investigations. 2020 Feb;38(2):37.e1-37.e9. (JCR Q2, IF2.954)（通讯作者）
Zhai, T-S#, Jin L#, Zhou Z, Liu X, Liu H, Chen W, Lu J-Y, Yao X-D*, Feng L-M*, Ye L*. Effect of lymph node dissection on stage-specific survival in patients with upper urinary tract urothelial carcinoma. BMC Cancer. 2019 Dec 12;19(1):1207. doi: 10.1186/s12885-019-6364-z.(JCR Q2, IF4.430)（通讯作者）
Guo Y#, Shi D#, Mao S, Zhang J, Wang L, Zhang W, Zhang Z, Jin L, Yang B, Ye L*, Yao X*. The Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) Score is a Novel Significant Prognostic Factor for Patients with Metastatic Prostate Cancer Undergoing Cytoreductive Radical Prostatectomy. Journal of Cancer. 2019 Jan 1;10(1):81-91.(JCR Q2, IF4.207)（共同通讯作者）
Ye L#, Yao X-D#, Wan F-N#, Qu Y-Y, Liu Z-Y, Yue F, Shen X-X, Li S, Wang N, Liu X-J, Dai B, Ye D-W*. MS4A8B promotes cell proliferation in prostate cancer. The Prostate. 2014;74(9):911-922. (JCR Q2, IF4.104)（第一作者）
Ye L#, Li S#, Ye D*, Yang D, Yue F, Guo Y, Chen X, Chen F, Zhang J*, Song X*. Livin expression may be regulated by miR-198 in human prostate cancer cell lines. European Journal of Cancer. 2013, 49(3):734-740. (JCR Q1, IF9.162)（第一作者）
Ye L, Zhao L, Yue F, Song X, Wei W, Jiang X, Yang J*. A large ureteral fibroepithelial polyp lacking epithelium due to ischemic infarction---case report and literature review. Kaohsiung Journal of Medical Sciences. 2012, 28(8):457-61.(JCR Q3, IF 2.744)（第一作者）
Ye L, Song X*, Li S, Yang D, Zhang J, Che X, Chen X, Wang J, Zhang Z. Livin-alpha promotes cell proliferation by regulating G1-S cell cycle transition in prostate cancer. The Prostate. 2011, 71(1):42-51.( JCR Q2, IF4.104)（第一作者）
Qin X#, Ye L#, Zhang H, Dai B, Zhu Y, Shi G, Ye D*. Complicated variation of simple renal cyst usually means malignancy: results from a cohort study. World Journal of Surgical Oncology. 2014 Oct 15;12:316. doi: 10.1186/1477-7819-12-316. (JCR Q2, IF2.754)（共同第一作者）
京公网安备 11010802027423号